![Barry Quart](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Barry Quart
Directeur Général chez
CONNECT BIOPHARMA HOLDINGS LIMITED
Fortune : 1 M $ au 31/05/2026
Profil
Barry D.
Quart was the founder of Ardea Biosciences, Inc., founded in 2006, where the titles held included President, Chief Executive Officer & Director from 2012 to 2013.
Current jobs include Chief Executive Officer & Director at Connect Biopharma Holdings Ltd. starting in 2024; Director at NeuroGenetic Pharmaceuticals, Inc.; Independent Director at Kiniksa Pharmaceuticals Ltd. since 2015; Director at Kiniksa Pharmaceuticals Corp.; and Independent Director at Kiniksa Pharmaceuticals International Plc starting in 2024.
Former jobs include Chairman & Chief Executive Officer at Heron Therapeutics, Inc. from 2020 to 2023; Director at Trimeris, Inc. from 2007 to 2011; Director, SVP-Global Research & Development at Pfizer (La Jolla); Independent Director at Synageva BioPharma Corp.
from 2012 to 2015; President-Research & Development at Agouron Pharmaceuticals LLC; Senior VP-Pfizer Global Research & Development at Pfizer Inc.; and President at Napo Pharmaceuticals, Inc. from 2002 to 2006.
Education includes a doctorate from The University of California, San Francisco.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
0,03 % | 29/05/2026 | 15 345 ( 0,03 % ) | 742 391 $ | 31/05/2026 |
| 16/03/2026 | 224 034 ( 0,4 % ) | 557 845 $ | 31/05/2026 |
Postes actifs de Barry Quart
| Sociétés | Poste | Début |
|---|---|---|
| CONNECT BIOPHARMA HOLDINGS LIMITED | Directeur Général | 12/06/2024 |
NeuroGenetic Pharmaceuticals, Inc.
 NeuroGenetic Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops drugs for the prevention of neurodegenerative conditions | Directeur/Membre du Conseil | - |
Kiniksa Pharmaceuticals Ltd.
 Kiniksa Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops and delivers therapeutic medicines for patients suffering from cardiovascular diseases | Directeur/Membre du Conseil | 01/10/2015 |
Kiniksa Pharmaceuticals Corp.
 Kiniksa Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage biopharmaceutical company which develops and commercializes therapeutic medicines for patients suffering from debilitating diseases | Directeur/Membre du Conseil | - |
Anciens postes connus de Barry Quart
| Sociétés | Poste | Fin |
|---|---|---|
| HERON THERAPEUTICS, INC. | Directeur Général | 03/04/2023 |
| SYNAGEVA BIOPHARMA CORP | Directeur/Membre du Conseil | 22/06/2015 |
Ardea Biosciences, Inc.
 Ardea Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops small molecule therapeutics | Fondateur | 01/05/2013 |
Trimeris, Inc.
 Trimeris, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for viral diseases | Directeur/Membre du Conseil | 04/11/2011 |
Napo Pharmaceuticals, Inc.
 Napo Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets human gastrointestinal pharmaceuticals | President | 01/12/2006 |
Formation de Barry Quart
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
60
Relations au 1er degré
13
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 13 |
|---|---|
Heron Therapeutics, Inc.
 Heron Therapeutics, Inc. BiotechnologyHealth Technology Manufactures and commercializes of polymer technologies | Health Technology |
Agouron Pharmaceuticals LLC
 Agouron Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Develops and distributes therapeutic products | Health Technology |
Pfizer Inc.
 Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
Trimeris, Inc.
Trimeris, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for viral diseases | Health Technology |
Napo Pharmaceuticals, Inc.
Napo Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets human gastrointestinal pharmaceuticals | Health Technology |
NeuroGenetic Pharmaceuticals, Inc.
NeuroGenetic Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops drugs for the prevention of neurodegenerative conditions | Health Technology |
The University of California, San Francisco
 The University of California, San Francisco Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ardea Biosciences, Inc.
Ardea Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops small molecule therapeutics | Health Technology |
Pfizer (La Jolla)
 Pfizer (La Jolla) Miscellaneous Commercial ServicesCommercial Services Provides research services | Commercial Services |
Synageva BioPharma Corp.
 Synageva BioPharma Corp. BiotechnologyHealth Technology Develops and manufactures biopharmaceutical products | Health Technology |
Kiniksa Pharmaceuticals Ltd.
Kiniksa Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops and delivers therapeutic medicines for patients suffering from cardiovascular diseases | Health Technology |
Kiniksa Pharmaceuticals Corp.
Kiniksa Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage biopharmaceutical company which develops and commercializes therapeutic medicines for patients suffering from debilitating diseases | Health Technology |
Connect Biopharma Holdings Ltd.
 Connect Biopharma Holdings Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
